CJC-1295 vs Pramlintide

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

CJC-1295 is primarily a performance & growth peptide, while Pramlintide is used for weight management & metabolic.

This page compares CJC-1295 and Pramlintide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

CJC-1295Pramlintide
CategoryPerformance & GrowthWeight Management & Metabolic
Regulatory status (US)Research use onlyFDA approved
Typical dosage1-2 mg60-120 mcg
Frequencyweeklywith meals
Reported benefitsIncreased muscle mass, fat loss, improved recovery, better sleep, enhanced bone densityReduced post-meal glucose, weight loss, appetite control
Reported side effectsWater retention, joint pain, potential insulin resistance with prolonged useNausea, hypoglycemia risk with insulin

Key differences

Primary use. CJC-1295 is categorised under Performance & Growth, while Pramlintide falls under Weight Management & Metabolic. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. CJC-1295: not FDA-approved; treated as a research compound. Pramlintide: FDA-approved.

Dosing. CJC-1295 is typically dosed at 1-2 mg (weekly). Pramlintide is typically dosed at 60-120 mcg (with meals).

Can you stack them?

Some protocols combine peptides, but stacking CJC-1295 and Pramlintide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between CJC-1295 and Pramlintide?
CJC-1295 is primarily a performance & growth peptide, while Pramlintide is used for weight management & metabolic. CJC-1295 is not FDA-approved; generally classified as a research compound, whereas Pramlintide is FDA-approved for one or more indications.
What is CJC-1295 used for?
Growth hormone, muscle mass, fat loss.
What is Pramlintide used for?
Amylin analog for diabetes.
Can you take CJC-1295 and Pramlintide together?
Some users combine peptides within a single protocol, but stacking CJC-1295 and Pramlintide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is CJC-1295 or Pramlintide FDA-approved?
CJC-1295 is not FDA-approved; generally classified as a research compound. Pramlintide is FDA-approved for one or more indications.

Read the full articles

  • CJC-1295 — full monograph: mechanism, research, dosing & references
  • Pramlintide — full monograph: mechanism, research, dosing & references

More Performance & Growth comparisons

CJC-1295 compared across categories

← All peptide comparisons